Manfred Husemann

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Bayer Schering Pharma Ag, Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manfred Husemann. Retrieved from https://idiyas.com/inventor/manfred-husemann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 7)

Average Co-Inventor Count = 10.2

ph-index = 1

Forward Citations = 13(Granted Patents)

Company Filing History:

2 out of 192

Bayer Schering Pharma Ag

patents

1 out of 12,268

Bayer Aktiengesellschaft

patents

1 out of 387

Bayer Pharma Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2010-2021

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11161825 - 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides (2021-11-02),

2. 7842809 - Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same (2010-11-30),

3. 7750000 - Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments (2010-07-06),

Title: Manfred Husemann: Innovator in Pharmaceutical Chemistry

Introduction

Manfred Husemann is a notable inventor based in Hohen Neuendorf, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for the treatment of various diseases.

Latest Patents

Husemann holds three patents, showcasing his innovative work. His latest patents include the development of 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides. This invention covers compounds that are useful in manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, especially cancer. Another significant patent involves pyrazolopyridines and their salts, which are aimed at treating diseases associated with dysregulated vascular growth. These compounds effectively interfere with angiopoietin, influencing Tie2 signaling.

Career Highlights

Throughout his career, Husemann has worked with prominent companies in the pharmaceutical industry, including Bayer Schering Pharma AG and Bayer Aktiengesellschaft. His work has been instrumental in advancing pharmaceutical research and development.

Collaborations

Husemann has collaborated with notable professionals in his field, including Stuart Ince and Antonius Ter Laak. These collaborations have contributed to the success of his innovative projects.

Conclusion

Manfred Husemann's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to impact the development of treatments for critical health issues.

Profile summary based on public USPTO records.